• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评价载体材料对改善难溶性药物从液固体制剂中释放特性的影响。

Evaluation of the effect of carrier material on modification of release characteristics of poor water soluble drug from liquisolid compacts.

机构信息

Department of Pharmacy, Abasyn University, Peshawar, Pakistan.

Department of Pharmacy, Kohat University of Science and Technology (KUST), Kohat, Pakistan.

出版信息

PLoS One. 2021 Aug 2;16(8):e0249075. doi: 10.1371/journal.pone.0249075. eCollection 2021.

DOI:10.1371/journal.pone.0249075
PMID:34339440
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8328342/
Abstract

Liquisolid compact is a novel dosage form in which a liquid medication (liquid drug, drug solution/dispersion in non-volatile solvent/solvent system) is converted to a dry, free flowing powder and compressed. Objective of the study was to elucidate the effect of carrier material on release characteristics of clopidogrel from liquisolid compacts. Different formulations of liquisolid compacts were developed using microcrystalline cellulose, starch maize, polyvinyl pyrollidone and hydroxypropyl methylcellulose as carrier material in three concentrations (40, 30 and 20%, w/w). Liquid vehicle was selected on the basis of solubility of clopidogrel. Colloidal silicondioxide was used as coating material and ratio of carrier to coating material was kept 10. A control formulation comprised of microcrystalline cellulose (diluents), tabletose-80 (diluents), primojel (disintegrant) and magnesium stearate (lubricant) was prepared by direct compression technique and was used for comparison. All the formulations were evaluated at pre and post compression level. Acid solubility profile showed higher solubility in HCl buffer pH2 (296.89±3.49 μg/mL). Mixture of propylene glycol and water (2:1, v/v) was selected as liquid vehicle. Drug content was in the range of 99-101% of the claimed quantity. All the formulations showed better mechanical strength and their friability was within the official limits (<1%). Microcrystalline cellulose and starch maize resulted in faster drug release while polyvinyl pyrollidone and HPMC resulted in sustaining drug release by gel formation. It is concluded from results that both fast release and sustained release of clopidogrel can be achieved by proper selection of carrier material.

摘要

液固体制剂是一种新型剂型,将液体药物(液体药物、非挥发性溶剂/溶剂系统中的药物溶液/分散体)转化为干燥、自由流动的粉末并进行压缩。研究目的是阐明载体材料对氯吡格雷从液固体制剂中释放特性的影响。使用微晶纤维素、玉米淀粉、聚乙烯吡咯烷酮和羟丙基甲基纤维素作为载体材料,在三个浓度(40、30 和 20%,w/w)下开发了不同的液固体制剂配方。液体载体是根据氯吡格雷的溶解度选择的。胶体二氧化硅用作包衣材料,载体与包衣材料的比例保持在 10。采用直接压片技术制备由微晶纤维素(稀释剂)、麦芽糖糊精-80(稀释剂)、普鲁兰(崩解剂)和硬脂酸镁(润滑剂)组成的对照制剂,并用于比较。所有配方均在压缩前后进行评估。酸溶解度曲线显示在 HCl 缓冲液 pH2 中具有更高的溶解度(296.89±3.49μg/mL)。选择丙二醇和水(2:1,v/v)的混合物作为液体载体。药物含量在规定量的 99-101%范围内。所有配方均表现出更好的机械强度,其脆碎度在官方限度内(<1%)。微晶纤维素和玉米淀粉导致药物更快释放,而聚乙烯吡咯烷酮和 HPMC 通过凝胶形成导致药物持续释放。结果表明,通过适当选择载体材料可以实现氯吡格雷的快速释放和持续释放。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d7f/8328342/8b500c933007/pone.0249075.g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d7f/8328342/14ef487c66ff/pone.0249075.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d7f/8328342/3095b39c6691/pone.0249075.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d7f/8328342/4f669a40e067/pone.0249075.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d7f/8328342/fa6c8b7de4f3/pone.0249075.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d7f/8328342/59b7b1434f6d/pone.0249075.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d7f/8328342/7b2de5d07ec7/pone.0249075.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d7f/8328342/9f88ae69d4f2/pone.0249075.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d7f/8328342/fe5a9f9448f6/pone.0249075.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d7f/8328342/8b500c933007/pone.0249075.g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d7f/8328342/14ef487c66ff/pone.0249075.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d7f/8328342/3095b39c6691/pone.0249075.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d7f/8328342/4f669a40e067/pone.0249075.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d7f/8328342/fa6c8b7de4f3/pone.0249075.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d7f/8328342/59b7b1434f6d/pone.0249075.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d7f/8328342/7b2de5d07ec7/pone.0249075.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d7f/8328342/9f88ae69d4f2/pone.0249075.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d7f/8328342/fe5a9f9448f6/pone.0249075.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d7f/8328342/8b500c933007/pone.0249075.g009.jpg

相似文献

1
Evaluation of the effect of carrier material on modification of release characteristics of poor water soluble drug from liquisolid compacts.评价载体材料对改善难溶性药物从液固体制剂中释放特性的影响。
PLoS One. 2021 Aug 2;16(8):e0249075. doi: 10.1371/journal.pone.0249075. eCollection 2021.
2
Liquisolid technique for dissolution rate enhancement of a high dose water-insoluble drug (carbamazepine).用于提高高剂量水不溶性药物(卡马西平)溶出速率的液固技术
Int J Pharm. 2007 Aug 16;341(1-2):26-34. doi: 10.1016/j.ijpharm.2007.03.034. Epub 2007 Mar 30.
3
The effect of type and concentration of vehicles on the dissolution rate of a poorly soluble drug (indomethacin) from liquisolid compacts.载体的类型和浓度对难溶性药物(吲哚美辛)从液固分散体中的溶出速率的影响。
J Pharm Pharm Sci. 2005 Jan 12;8(1):18-25.
4
Effect of some commercial grades of microcrystalline cellulose on flowability, compressibility, and dissolution profile of piroxicam liquisolid compacts.某些商业级微晶纤维素对吡罗昔康液固型制剂的流动性、可压性及溶出曲线的影响
Drug Dev Ind Pharm. 2009 Feb;35(2):243-51. doi: 10.1080/03639040802277672.
5
Liquisolid Tablets for Dissolution Enhancement of a Hypolipidemic Drug.用于增强降血脂药物溶出度的液固混合片
Indian J Pharm Sci. 2015 May-Jun;77(3):290-8. doi: 10.4103/0250-474x.159618.
6
Liquisolid systems to improve the dissolution of furosemide.改善呋塞米溶出度的液固系统。
Sci Pharm. 2010 Apr-Jun;78(2):325-44. doi: 10.3797/scipharm.0912-23. Epub 2010 Apr 23.
7
Investigating the use of liquisolid compacts technique to minimize the influence of pH variations on loratadine release.研究利用固体制剂技术来最小化盐酸西替利嗪释放受 pH 值变化的影响。
AAPS PharmSciTech. 2012 Mar;13(1):53-8. doi: 10.1208/s12249-011-9719-6. Epub 2011 Nov 19.
8
Influence of formulation parameters on dissolution rate enhancement of glyburide using liquisolid technique.采用液质联用技术研究制剂参数对格列吡嗪溶出速率的影响。
Drug Dev Ind Pharm. 2012 Aug;38(8):961-70. doi: 10.3109/03639045.2011.634810. Epub 2012 Jan 18.
9
Effects of liquisolid formulations on dissolution of naproxen.液固体制剂对萘普生溶出度的影响。
Eur J Pharm Biopharm. 2009 Nov;73(3):373-84. doi: 10.1016/j.ejpb.2009.08.002. Epub 2009 Aug 11.
10
Suitability of various excipients as carrier and coating materials for liquisolid compacts.各种辅料作为载体和包衣材料用于液固压缩片的适用性。
Drug Dev Ind Pharm. 2011 Oct;37(10):1200-7. doi: 10.3109/03639045.2011.564184. Epub 2011 Mar 31.

引用本文的文献

1
Apixaban and clopidogrel in a fixed-dose combination: Formulation and in vitro evaluation.阿哌沙班与氯吡格雷的固定剂量组合:制剂与体外评价。
Saudi Pharm J. 2024 Jun;32(6):102089. doi: 10.1016/j.jsps.2024.102089. Epub 2024 Apr 29.
2
Olanzapine Liquisolid Tablets Using Kolliphor EL with Improved Flowability and Bioavailability: and Characterization.使用聚氧乙烯蓖麻油EL提高流动性和生物利用度的奥氮平液固混合片:及特性研究
Turk J Pharm Sci. 2024 Mar 25;21(1):52-61. doi: 10.4274/tjps.galenos.2023.05752.
3
Development and Evaluation of Self-Emulsifying Drug-Delivery System-Based Tablets for Simvastatin, a BCS Class II Drug.

本文引用的文献

1
Liquisolid technique and its applications in pharmaceutics.液固技术及其在药剂学中的应用。
Asian J Pharm Sci. 2017 Mar;12(2):115-123. doi: 10.1016/j.ajps.2016.09.007. Epub 2016 Nov 4.
2
Enhancement of dissolution rate of class II drugs (Hydrochlorothiazide); a comparative study of the two novel approaches; solid dispersion and liqui-solid techniques.提高 II 类药物(氢氯噻嗪)的溶出速率;两种新方法的比较研究;固体分散体和液-固技术。
Saudi Pharm J. 2015 Nov;23(6):650-7. doi: 10.1016/j.jsps.2015.01.025. Epub 2015 Feb 7.
3
PON1 Q192R genetic variant and response to clopidogrel and prasugrel: pharmacokinetics, pharmacodynamics, and a meta-analysis of clinical outcomes.
基于自乳化药物传递系统的辛伐他汀(BCS Ⅱ类药物)片剂的研制与评价。
Drug Des Devel Ther. 2023 Jan 26;17:261-272. doi: 10.2147/DDDT.S377686. eCollection 2023.
4
Formulation Development and Characterization of pH Responsive Polymeric Nano-Pharmaceuticals for Targeted Delivery of Anti-Cancer Drug (Methotrexate).用于靶向递送抗癌药物(甲氨蝶呤)的pH响应型聚合物纳米药物的制剂开发与表征
Front Pharmacol. 2022 Jun 30;13:911771. doi: 10.3389/fphar.2022.911771. eCollection 2022.
PON1 Q192R基因变异与对氯吡格雷和普拉格雷的反应:药代动力学、药效学及临床结局的荟萃分析
J Thromb Thrombolysis. 2016 Apr;41(3):374-83. doi: 10.1007/s11239-015-1264-9.
4
Clinical pharmacokinetics of clopidogrel and its metabolites in patients with cardiovascular diseases.氯吡格雷及其代谢产物在心血管疾病患者中的临床药代动力学
Clin Pharmacokinet. 2014 Feb;53(2):155-64. doi: 10.1007/s40262-013-0105-2.
5
Loss of orally administered drugs in GI tract.胃肠道中口服药物的损失。
Saudi Pharm J. 2012 Oct;20(4):331-44. doi: 10.1016/j.jsps.2012.03.005. Epub 2012 Apr 20.
6
Matrix tablets: the effect of hydroxypropyl methylcellulose/anhydrous dibasic calcium phosphate ratio on the release rate of a water-soluble drug through the gastrointestinal tract I. In vitro tests.基质片剂:羟丙基甲基纤维素/无水磷酸氢钙比例对水溶性药物经胃肠道释放速率的影响 I. 体外试验。
AAPS PharmSciTech. 2012 Dec;13(4):1073-83. doi: 10.1208/s12249-012-9829-9. Epub 2012 Aug 21.
7
Evaluation of in vitro dissolution profile comparison methods of sustained release tramadol hydrochloride liquisolid compact formulations with marketed sustained release tablets.盐酸曲马多液体固体致密制剂与市售缓释片体外溶出度曲线比较方法的评价
Drug Discov Ther. 2010 Feb;4(1):26-32.
8
Influence of formulation parameters on dissolution rate enhancement of glyburide using liquisolid technique.采用液质联用技术研究制剂参数对格列吡嗪溶出速率的影响。
Drug Dev Ind Pharm. 2012 Aug;38(8):961-70. doi: 10.3109/03639045.2011.634810. Epub 2012 Jan 18.
9
Enhancement of griseofulvin release from liquisolid compacts.从液固体制剂中增强灰黄霉素的释放。
Eur J Pharm Biopharm. 2012 Jan;80(1):130-5. doi: 10.1016/j.ejpb.2011.08.001. Epub 2011 Aug 9.
10
New clopidogrel napadisilate salt and its solid dispersion with improved stability and bioequivalence to the commercial clopidogrel bisulphate salt in beagle dogs.新型氯吡格雷萘二磺酸盐及其固体分散体在比格犬中与商业氯吡格雷二硫酸盐相比具有改善的稳定性和生物等效性。
Int J Pharm. 2011 Aug 30;415(1-2):129-39. doi: 10.1016/j.ijpharm.2011.05.059. Epub 2011 May 27.